Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma.
Visani G, Guiducci B, D'Adamo F, Mele A, Nicolini G, Leopardi G, Sparaventi G, Barulli S, Malerba L, Isidori A, Malagola M, Piccaluga PP. Visani G, et al. Among authors: malagola m. Leuk Lymphoma. 2005 Mar;46(3):477-9. doi: 10.1080/10428190400013688. Leuk Lymphoma. 2005. PMID: 15621843 No abstract available.
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study.
Malagola M, Polverelli N, Martino M, Patriarca F, Bruno B, Giaccone L, Grillo G, Bramanti S, Bernasconi P, De Gobbi M, Natale A, Terruzzi E, Olivieri A, Chiusolo P, Carella AM, Casini M, Maffini E, Nozzoli C, Mazza P, Bassi S, Onida F, Vacca A, Falcioni S, Luppi M, Iori AP, Pavone V, Skert C, Carluccio P, Borghero C, Proia A, Selleri C, Rubini V, Sacchi N, Oldani E, Bonifazi F, Ciceri F, Russo D. Malagola M, et al. Transplant Direct. 2023 Feb 22;9(3):e1451. doi: 10.1097/TXD.0000000000001451. eCollection 2023 Mar. Transplant Direct. 2023. PMID: 36845852 Free PMC article.
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation.
Malagola M, Radici V, Farina M, Pellizzeri S, Spoldi F, Morello E, Polverelli N, Buttini EA, Bernardi S, Re F, Leoni A, Signorini L, Caruso A, Russo D. Malagola M, et al. Bone Marrow Transplant. 2024 Feb;59(2):293. doi: 10.1038/s41409-023-02158-2. Bone Marrow Transplant. 2024. PMID: 38030882 Free PMC article. No abstract available.
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia.
Malagola M, Polverelli N, Beghin A, Bolda F, Comini M, Farina M, Morello E, Radici V, Accorsi Buttini E, Bernardi S, Re F, Leoni A, Bonometti D, Brugnoni D, Lanfranchi A, Russo D. Malagola M, et al. Front Oncol. 2023 Mar 6;13:1133418. doi: 10.3389/fonc.2023.1133418. eCollection 2023. Front Oncol. 2023. PMID: 36950550 Free PMC article.
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation.
Malagola M, Radici V, Farina M, Pellizzeri S, Spoldi F, Morello E, Polverelli N, Buttini EA, Bernardi S, Re F, Leoni A, Signorini L, Caruso A, Russo D. Malagola M, et al. Bone Marrow Transplant. 2024 Jan;59(1):138-140. doi: 10.1038/s41409-023-02124-y. Epub 2023 Oct 19. Bone Marrow Transplant. 2024. PMID: 37857841 Free PMC article. No abstract available.
Chemotherapy of secondary leukemias.
Visani G, Pagano L, Pulsoni A, Tosi P, Piccaluga PP, Pastano R, Grafone T, Malagola M, Isidori A, Tura S. Visani G, et al. Among authors: malagola m. Leuk Lymphoma. 2000 May;37(5-6):543-9. doi: 10.3109/10428190009058506. Leuk Lymphoma. 2000. PMID: 11042514 Review.
Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia.
Visani G, Milligan D, Leoni F, Chang J, Kelsey S, Marcus R, Powles R, Schey S, Covelli A, Isidori A, Litchman M, Piccaluga PP, Mayer H, Malagola M, Pfister C. Visani G, et al. Among authors: malagola m. Leukemia. 2001 May;15(5):764-71. doi: 10.1038/sj.leu.2402117. Leukemia. 2001. PMID: 11368437 Clinical Trial.
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients.
Visani G, Bernasconi P, Boni M, Castoldi GL, Ciolli S, Clavio M, Cox MC, Cuneo A, Del Poeta G, Dini D, Falzetti D, Fanin R, Gobbi M, Isidori A, Leoni F, Liso V, Malagola M, Martinelli G, Mecucci C, Piccaluga PP, Petti MC, Rondelli R, Russo D, Sessarego M, Specchia G, Testoni N, Torelli G, Mandelli F, Tura S. Visani G, et al. Among authors: malagola m. Leukemia. 2001 Jun;15(6):903-9. doi: 10.1038/sj.leu.2402142. Leukemia. 2001. PMID: 11417475 Review.
Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients.
Visani G, Lemoli RM, Isidori A, Piccaluga PP, Martinelli G, Malagola M, Gugliotta L, Bonini A, Bonifazi F, Motta MR, Rizzi S, Castellani S, Tura S. Visani G, et al. Among authors: malagola m. Bone Marrow Transplant. 2001 Apr;27(8):829-35. doi: 10.1038/sj.bmt.1703003. Bone Marrow Transplant. 2001. PMID: 11477440 Clinical Trial.
152 results